Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder

Clinical trial NCT05999240 · RECRUITING

Trial details

NCT number: NCT05999240
Sponsor: New York State Psychiatric Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorder

Start date: 2025-10-01
Primary completion: 2026-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.